FDA Antiperspirant Monograph Partial Stay Permits Enhanced Duration
This article was originally published in The Rose Sheet
Executive Summary
Under a partial stay of the OTC Antiperspirant Monograph, products claiming enhanced duration up to 48 hours will be permitted on the market while FDA reviews new data, the agency says in an Oct. 15 Federal Register notice